Greenberg Traurig, LLP represented Hangzhou Zhongmei Huadong Pharmaceutical and Huadong Medicine Co. on the matter. Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage biopharmaceutical company focused...
Hangzhou Zhongmei Huadong Pharmaceutical Co..’s Licensing Agreement with Arcutis Biotherapeutic
Hangzhou Zhongmei Huadong Pharmaceutical’s Licensing Agreement with MC2 Therapeutics
Greenberg Traurig, LLP represented Hangzhou Zhongmei Huadong Pharmaceutical and Huadong Medicine Co. on the matter. Hangzhou Zhongmei Huadong Pharmaceutical, a subsidiary of Huadong Medicine, negotiated a licensing agreement...
Huadong Medicine’s Collaboration with Kiniksa Pharmaceuticals
Greenberg Traurig represented Huadong Medicine on the deal, while Ropes & Gray advised Kiniksa Pharmaceuticals. Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., a wholly owned subsidiary of...
InnovHeart’s $55 Million Round C Financing
IN BRIEF: Greenberg Traurig LLP, Greenberg Traurig Santa Maria, Shearman & Sterling, advised on the matter. Greenberg Traurig LLP advised Grand Pharma Pharmaceutical Group with a...